Skip to main content
. Author manuscript; available in PMC: 2019 Aug 1.
Published in final edited form as: Drug Alcohol Depend. 2018 May 24;189:21–29. doi: 10.1016/j.drugalcdep.2018.04.022

Table 2.

Mean Baseline Values of HIV Disease Severity Across Baseline AUDIT-C Score Categories for Both Analytic Samples*

CD4 Sample (n= 21,999) Test for Trend p-value
Baseline AUDIT-C Score N Mean (SD) Baseline CD4 <0.001

0 10372 511.3 (303.8)
1–3 (1–2 for women) 8760 516.7 (293.6)
4–5 (3–5 for women) 1676 506.0 (284.2)
6–7 512 504.2 (313.5)
8–12 679 434.7 (278.0)

Viral Load Sample (n=22,143)

Baseline AUDIT-C Score N Mean (SD) Baseline logVL** <0.001

0 10434 2.97 (0.68)
1–3 (1–2 for women) 8828 3.03 (0.74)
4–5 (3–5 for women) 1705 3.06 (0.74)
6–7 502 3.11 (0.80)
8–12 674 3.26 (0.88)

N (%) with Detectable VL <0.001

0 10434 1,979 (19.0)
1–3 (1–2 for women) 8828 2,011 (22.8)
4–5 (3–5 for women) 1705 447 (26.2)
6–7 502 149 (29.7)
8–12 674 246 (36.5)
*

Analyses were conducted at the patient (as opposed to the observation) level

**

Estimates for baseline logVL are high relative to current targets for suppression (<1.7 logs / < 50); viral suppression in the present study was at <2.7 logs / <500 copies/ml.